Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-472-4 | CAS number: 182700-89-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
The substance is expected to have an oral absorption of 50%, a dermal absorption of 25% and an inhalation absorption of 100%.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 25
- Absorption rate - inhalation (%):
- 100
Additional information
Introduction
The physico-chemical properties and the results of in vitro studies and acute and repeat dose toxicity studies with animals for benzoic acid, 2-hydroxy-,C14-18 alkyl derivs.,have been used to determine a toxicokinetic profile.
Physicochemical properties
The substance, benzoic acid, 2-hydroxy-,C14-18 alkyl derivs., is a clear brown viscous liquid. It is sparingly water soluble (45.7 ± 4.3 µg/L at 20 °C (Wildlife International Ltd., 2010)) with a logP value of 4.54 ± 0.11 at 40 °C (Wildlife International Ltd., 2010). Benzoic acid, 2 -hydroxy-,C14-18 alkyl derivs. contain a carboxylic acid and are therefore weakly acidic in nature, with a pH of 1.7 (1 M) and pKa of 3.4 at 20 °C (Shell International Petroleum Co., 1998). Benzoic acid, 2-hydroxy-,C14-18 alkyl derivs. are hydrolytically stable at pH 4, 7 and 9 at 50 °C for five days (Shell International Petroleum Co., 1998). Table 1 presents a summary of the physicochemical properties.
Table 1: Chemical Properties
Property |
benzoic acid, 2-hydroxy-,C14-18 alkyl derivs. |
Reference |
Water solubility |
46 µg/L |
(Wildlife International Ltd., 2010) |
LogP |
4.54 at 40 °C |
(Wildlife International Ltd., 2010) |
pH (1M) |
1.7 |
Calculated |
pKa |
3.4 at 20 °C |
(Shell International Petroleum Co., 1998) |
Hydrolysis |
Stable |
(Shell International Petroleum Co., 1998) |
Absorption
Oral absorption
An acute oral study (Latour, Report No. 506481, 2014) indicates that uptake does occur, with some systemic signs being noted at the administered dose (2000 mg/kg). In the 28 day study (Beerens-Heijnen, 2015) a NOAEL of 100 mg/kg bw/day was obtained, again indicating that oral uptake does occur. Very little on the quantitative value of oral absorption can be inferred from these studies. The substance has a molecular weight < 500, which is favourable for uptake. A pKa of 3.4 means that the substance is likely to be protonated in the stomach (pH 2-3) where some absorption can occur, but in the intestines (pH 5-9) where absorption is most common it will be deprotonated, making absorption less likely. The substance is also highly lipophilic (logP 4.54) and has low water solubility (46 µg/L), and this too may limit absorption. In the absence of quantitative data oral absorption is set to 50% for the purposes of risk assessment.
Dermal absorption
Benzoic acid, 2-hydroxy-,C14-18 alkyl derivs. causes slight skin irritation (Pharmaco LSR Ltd., 1995), is a skin sensitiser (Pharmaco LSR Ltd., 1995) and showed slight toxic signs during an acute dermal toxicity test (Latour, Report No. 506482, 2014), indicating that dermal absorption has occurred. However, the extent to which dermal absorption occurs is unclear. Therefore, for the purposes of risk assessment estimation of mammalian dermal absorption is made in accordance with principles adopted by the EFSA guidance on estimating dermal absorption of pesticide active substances (EFSA, 2012). On this basis, dermal absorption for the substance is assumed to be 25%.
Inhalation absorption
In the absence of quantitative information, complete absorption (100%) following inhalation is assumed for the purposes of risk assessment.
Distribution
It can be expected that once absorbed the substance will be widely distributed throughout the body.
Metabolism
There is no metabolism data available for this substance. Conjugation is likely to occur, which will increase the water solubility and make the substance easier to excrete. There is considered to be no potential for bioaccumulation.
Elimination
Although there is no elimination data available for this substance, compounds with a molecular weight > 300 tend to be excreted in the bile, not the urine.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.